Skip to main content

CON-TGO91-317 - Sanofi-Aventis Australia Pty Ltd

Product names
  • AUST R 12406 - LASIX furosemide (frusemide) 40mg tablet bottle
  • AUST R 12408 - LASIX HIGH DOSE furosemide (frusemide) 250mg/25mL injection ampoule
  • AUST R 12409 - LASIX M furosemide (frusemide) 20mg tablet bottle
  • AUST R 232815 - LASIX furosemide (frusemide) 10mg/mL oral liquid bottle
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 31 March 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site